Investment in research to tackle poverty-related and neglected diseases – such as TB and malaria – has fallen since the COVID-19 pandemic, according to Andrew Tuttle, chief strategy officer of Policy Cures Research. After rising steadily, annual investment in such research began to plateau in 2018 and then declined in the wake of the pandemic, he told a session entitled Deepening cooperation with the Global South for sustainable health futures at the Science|Business Annual Conference, organised in partner
Related Keywords
France , Dakar , Senegal , Brussels , Bruxelles Capitale , Belgium , South Africa , French , Benjamin Roche , Glenda Gray , Andrew Tuttle , Maria Cristina Russo , Peter Piot , Gates Foundation Grand , Countries Clinical Trials Partnership , Cures Research , African Medical Research Council , African Union , European Eu Global Health Strategy , Eu Framework Programme , European Commission , French National Research Institute For Sustainable Development , Policy Cures , Global South , Business Annual Conference , Developing Countries Clinical Trials Partnership , French National Research Institute , Sustainable Development , South African Medical Research Council , Gates Foundation Grand Challenges , Health Strategy ,
vimarsana.com © 2020. All Rights Reserved.